Of the 89 pairs of CRC tissues, 65% (58 out of 89) showed higher expression of ERp29 in tumor tissues compared with adjacent non-tumor tissues, while only 35% (31 out of 89) showed downregulation of ERp29 in tumor tissues compared with adjacent non-tumor tissues (Fig. 2F). This evidence concerns the gene ERP29 and neoplasm.